FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083551 [Registered on: 26/03/2025] Trial Registered Prospectively
Last Modified On: 10/11/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Evaluating Indian Tools for Estimating Gestational Age During Pregnancy 
Scientific Title of Study   A Multicentric Evaluation of Indian Population-Specific Tools for Antenatal Estimation of Gestational Age 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shinjini Bhatnagar 
Designation  Distinguished Professor 
Affiliation  Translational Health Science and Technology Institute 
Address  NCR Biotech Science Cluster 3rd Milestone, Faridabad-Gurgaon Expressway, Post Box #04 Faridabad-121001

Faridabad
HARYANA
121001
India 
Phone  -1292876351  
Fax    
Email  shinjini.bhatnagar@thsti.res.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bapu Koundinya Desiraju 
Designation  Principal Scientist - I 
Affiliation  Translational Health Science and Technology Institute 
Address  NCR Biotech Science Cluster 3rd Milestone, Faridabad-Gurgaon Expressway, Post Box #04 Faridabad-121001

Faridabad
HARYANA
121001
India 
Phone  9971675400  
Fax    
Email  bapukoundinyadesiraju@thsti.res.in  
 
Details of Contact Person
Public Query
 
Name  Dr Ramachandran Thiruvengadam 
Designation  Assistant Professor (Biochemistry) 
Affiliation  Pondicherry Institute of Medical Sciences 
Address  Pondicherry Institute of Medical Sciences, (A Unit of Madras Medical Mission), Puducherry - 605 014, INDIA

Pondicherry
PONDICHERRY
605 014
India 
Phone  9968859583  
Fax    
Email  ramachandran@thsti.res.in  
 
Source of Monetary or Material Support  
Biotechnology Industry Research Assistance Council BIRAC 
 
Primary Sponsor  
Name  Biotechnology Industry Research Assistance Council BIRAC 
Address  1st Floor, MTNL Building, 9, CGO Complex, Lodhi Road, New Delhi - 110003 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 10  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aparna Sharma  AIIMS Delhi  Sri Aurobindo Marg Ansari Nagar Ansari Nagar East New Delhi Delhi 110029
New Delhi
DELHI 
9711824415

kaparnasharma@gmail.com 
Dr Deb Boruah  AIIMS Guwahati  Silbharal Changsari, Guwahati, Assam 781101
Kamrup
ASSAM 
9435773549

debpal80@gmail.com 
Dr Smita Pawar  Fernandez hospital educational and research foundatio  4-1-1230, Bogulkunta Rd, near Abids, Bogulkunta, Abids, Hyderabad, Telangana 500001
Hyderabad
TELANGANA 
9676263405

drsmita.pawar@fernandez.foundation 
Dr Himanshu Sinha  Indian Institute of Technology Madras   Indian Institute of Technology Madras IIT P.O., Chennai 600 036 INDIA. State: Tamil Nadu
Chennai
TAMIL NADU 
9769732211

hsinha@smail.iitm.ac.in 
Dr Sadhana Joshi  IRSHA BVDU Pune  Pune Satara Road, Katraj-Dhankawadi, Pune – 411 043
Pune
MAHARASHTRA 
8007945167

sadhana.joshi@bharatividyapeeth.edu 
Dr Anjoo Agarwal  King Georges Medical University  Shah Mina Rd Chowk Lucknow Uttar Pradesh 226003
Lucknow
UTTAR PRADESH 
9450401972

anjooa@gmail.com 
Dr Sangeeta Gupta  Maulana Azad Medical College  2, Bahadur Shah Zafar Marg near Delhi Gate Maulana Azad Medical College Campus Balmiki Basti New Delhi Delhi 110002
New Delhi
DELHI 
8368199481

drsangeetamamc@gmail.com 
Dr Mary Daniel  Pondicherry Institute of Medical Sciences  Kalathumettupathai, Ganapathichettikulam Village No.20, Kalapet, Puducherry 605014
Pondicherry
PONDICHERRY 
9894052513

marydaniel309@gmail.com 
Dr Ranadip Chowdhury  Society for Applied Sciences (SAS)  45, Vijay Mandal Enclave, Kalu Sarai, New Delhi, Delhi 110016
New Delhi
DELHI 
7838870359

ranadip.chowdhury@sas.org.in 
Dr Nitya Wadhwa  Translational Health Science and Technology Institute   NCR Biotech Science Cluster 3rd Milestone गुडगाँव - फरीदाबाद मार्ग Faridabad-GurgaonExpressway, Faridabad, Haryana 121001
Faridabad
HARYANA 
9811142248

nitya.wadhwa@thsti.res.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 9  
Name of Committee  Approval Status 
IIT Madras Institutional Human Ethics Committee (IITM-IHEC)  Approved 
Institute Ethics committee AIIMS Delhi   Approved 
Institute Ethics committee AIIMS Guwahati  Approved 
Institutional Ethics committee (Human Studies) PIMS  Approved 
Institutional Ethics Committee(Biomedical and Health Research), THSTI  Approved 
Institutional Ethics committee, Fernandez Hospital  Approved 
Institutional Ethics Committee, KGMU  Approved 
Institutional Ethics committee, Maulana Azad Medical college   Approved 
Institutional Ethics Committee,Bharati Vidyapeeth Deemed To be University Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O00-O08||Pregnancy with abortive outcome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Pregnant women age more than 18 years in the first trimester of pregnancy (9 to 14 weeks) as confirmed by first-trimester dating ultrasound
2. Women willing to provide consent for study participation
3. Women should be able to visit the study site for regular follow-up and delivery
 
 
ExclusionCriteria 
Details  Multifetal gestation
Extra uterine pregnancy
Molar pregnancy
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Accurate estimation of gestational age during second and third trimester by GA2 and GUAGE compared with gold standard GA1  Baseline ( 9 to 14 weeks), follow-up (15 to 40 weeks), Delivery 
 
Secondary Outcome  
Outcome  TimePoints 
Ways to integrate the models into the workflow of sonologists and obstetricians
Engage with original equipment manufacturers to enable the last-mile translation and implementation of the GA assessment tools 
Analyzed post study  
 
Target Sample Size   Total Sample Size="4000"
Sample Size from India="4000" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title : A Multicentric Evaluation of Indian Population-Specific Tools for Antenatal Estimation of Gestational Age

Background

The GARBH-Ini program, initiated in 2015 by THSTI at Civil Hospital, Gurugram, Haryana, focuses on understanding adverse pregnancy outcomes and developing solutions. It has enrolled over 10,000 pregnant women, collecting detailed demographic, clinical, and ultrasound data. Accurate gestational age (GA) estimation is essential for effective obstetric care, including screening for fetal anomalies, monitoring growth, and ensuring accurate epidemiological data. Traditional GA estimation methods like LMP-based dating are often inaccurate, particularly in India, due to variations in fetal growth and late antenatal care initiation.

The program has developed three Indian population-specific GA estimation tools:

  1. Garbhini-GA1: First-trimester CRL-based model.
  2. Garbhini-GA2: Second and third-trimester biometry-based model, more accurate than Hadlock and INTERGROWTH-21st models.
  3. GAUGE: Image-based tool using raw ultrasound images, achieving high accuracy across internal and external validations.

This study aims to validate these tools across multiple Indian sites, considering factors such as State of residence (a surrogate for ethnic differences) , Socioeconomic status, Maternal anthropometric characteristics, Manufacturer of ultrasound machines and probes Level of experience and training in ultrasonography


Objectives

  1. Assess the accuracy and precision of the Garbhini-GA2 formula using longitudinal ultrasound data.
  2. Validate the GAUGE tool by collecting fetal head ultrasound images and comparing its predictions with the ground truth.

Study Methods

  • Design: Prospective cohort study with retrospective data collection at select sites (SAS).
  • Population: First-trimester pregnant women (9–14 weeks).
  • Sample Size: 4,000 participants (1,000 per region).
  • Study Duration: 2 years.

Inclusion Criteria

  • Pregnant women aged >18 years, confirmed in the first trimester (9–14 weeks).
  • Consent to participate and willingness to attend follow-ups.

Exclusion Criteria:

  • Multifetal gestation, extrauterine pregnancy, or molar pregnancy.

Data Collection

  1. Prospective:

    • Four ultrasounds per participant (dating, 18–22 weeks, 32–36 weeks, and an additional scan customized for gestational distribution).
    • Data includes demographics, maternal/paternal anthropometrics, clinical history, and ultrasound data.
  2. Retrospective:

    • Data extraction from existing research databases (applicable to SAS).

Analysis Plan

  • First-trimester USG-based dating serves as the gold standard GA.
  • Estimated GA from Garbhini-GA2 and GAUGE models will be compared against the gold standard.
  • Metrics: Distribution of errors, Bland-Altman analysis for bias, Cohen’s kappa for agreement.
  • Subgroup analyses based on BMI, socioeconomic status, parity, and fetal growth status (FGR/SGA).

The study will also benchmark Indian models against global ones to ensure robust performance.


This research aims to enhance GA estimation in Indian settings, enabling more accurate and equitable maternal-fetal healthcare delivery.

 
Close